All prostate tumors were found to be hypermethylated in both ALOX12 and PDGFRB, while the 2 BPH samples remained unmethylated (Spearman coefficient 0.67 and 0.78 respectively) (Figure 3). Here, ALOX12 is linked to benign prostatic hyperplasia.